Carlos Enrique Fardella Bello
Profesor Titular
PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE
Santiago, Chile
HYPERTENSION; METABOLIC SYNDROME; PRIMARY HYPERALDOSTERONISM; DIABETES; AXIS CORTISOL; Endocrine hypertension sensitive to salt; Metabolic disorders; Adrenal Pathology; Pituitary tumors; Cardio-metabolic risk; Pediatric arterial hypertension.
-
Médico Cirujano, Universidad de Chile. Chile, 1982
-
Master in Medicine, PONTIFICIA UNIVERSIDAD CATOLICA DE CHILE. Chile, 1986
-
Endocrinología Full Time
Pontificia Universidad Catolica de Chile
Medicine
Santiago, Chile
1986 - 1988
-
Profesor Titular Full Time
Pontificia Universidad Católica de Chile
Medicina
Santiago, Chile
2007 - A la fecha
-
Postdoctorado en Biologia Molecular Full Time
University of California, San Francisco
Medicina
San Francisco, Estados Unidos
1991 - A la fecha
-
Medicina Interna Full Time
Pontificia Universidad Católica de Chile
Medicina
Santiago, Chile
1983 - 1988
-
Becario Other
Pontificia Universidad Católica de Chile
Medicina
Chile, Chile
1983 - 1986
-
Full Professor Full Time
Pontificia Universidad Católica de Chile
Santiago, Chile
2007 - A la fecha
-
Associated Researcher Full Time
Pontificia Universidad Católica de Chile
Santiago, Chile
1988 - 1990
-
Associated Instructor Full Time
Pontificia Universidad Católica de Chile
Santiago, Chile
1990 - 1995
-
Adjunct Professor Full Time
Pontificia Universidad Católica de Chile
Santiago, Chile
1998 - 2006
-
Assistant Professor Full Time
Pontificia Universidad Católica de Chile
Santiago, Chile
1995 - 1998
1995 Jun -: Head of the Molecular Biology Program for endocrinology fellows, 4 hours per week for 6 months. , P.Universidad Católica de Chile
1995 Jun -: tutorial Teaching in Clinical Endocrinology to grantees endocrinology and internal medicine, 3 hours per week, for 3 months. , P.Universidad Católica de Chile
1995 Jun -: tutorial for medical students that perform training passes Molecular Biology, 2 hours a week during most of the year teaching, P.Universidad Católica de Chile
1995 Jun -: Teaching tutorial to biochemical and technologists in the management of molecular techniques to the study of genetic diseases, 4 hours a week for most of the year. , P.Universidad Católica de Chile
1995 Jun -: Lecturer in Molecular Pathology course for Bioquimicos. BIO 241 B (before 3334) (1 class / year), Catholic P.Universidad Chile
1995 Jun -: Professor at the Integrated Medical and Surgical Clinics Course. MEC 246 GH (3 seminars per year). , P.Universidad Católica de Chile
Jan 1997 -: Teaching in the Course of Medical Genetics for medical students. MEC 260 (1 class / year), P.Universidad Católica de Chile
Jan 1997 -: Teaching in the Course of Molecular Biology of Celula.BIO 238 (1 class / year), P.Universidad Católica de Chile
Jan 1998 -: Professor in the Doctoral Program in Medical Sciences: Biological Processes in Human Disease Basic. MDO 1020 (2 seminars / year), P.Universidad Católica de Chile
Mar 1998 -: Professor in Charge of the Teachers Stays in the Laboratory of Molecular Biology graduate students of the Fellowship in Endocrinology, Faculty of Medicine, Catholic University of Chile.
1998 Oct -: Professor at the Integrated Medical-Surgical Clinics course. Semiologia chapter. Mec 231-A, 72 hours, P.Universidad Católica de Chile
Mar 2004 - Sep 2005: Part of the Evaluation Commission Project Thesis: Optimization of Culture Conditions of Parathyroid Cells for Cell Therapy in Hypoparathyroidism. Dr. Patricio Cabane Toledo. Doctoral Program in Medical Sciences and Clinical Specialty (Surgery). , University of Chile, Faculty of Medicine
2004 Oct - 2004 Oct: 3rd Workshop "Thyroid for medical non-specialists", organized by the Department of Endocrinology at the Catholic University of Chile in Santiago on October 16, 2004, Pontifical Catholic University of Chile
Aug 2005 - Aug 2005: Part of the Commission for the assessment of Progress Seminar Thesis: "Optimization of cell culture conditions parathyroid cell therapy for hypoparathyroidism" Cabane Dr. Patricio Toledo, Fac Medicine, Esc. . Post Graduate, University of Chile
2005 Jun - 2005 Jun: Teacher Manager (BIO295A) Departmental Research Seminar, Mauricio Morales B. Bachelor of Biochemistry, Fac BB CC, P. Catholic University of Chile.
Mar 2005 -: Teaching tutorial 2 cycles in Ambulatory Teaching 4th year (MEC246GH), held at the San Joaquin Medical Center. 1st and 2nd semesters. 2005, Pontifical Catholic U of Chile
Mar 2005 -: Part of the Commission for evluacion Project Research Report: "· Cortisol and its receptor in the genesis of human arterial hypertension: possible etiopathogenic mechanism." Miss. Paola Krall School of Biochemistry, Fac. Chemistry. Pontificia U Catolica de Chile
2005 Nov -: Professor of Classes and Seminars Integrated Course for Medical-Surgical Clinical Endocrinology Chapter III-MEC-246 students in four years. , Pontifical Catholic University of Chile
Sep 2005 - Sep 2005: Part of the Commission for the evaluation of Project Thesis Doctoral Program in Medical Sciences. Thesis "Interaction of glucocorticoid inhibitory factor and macrophage migration in a murine model of septic shock" Mr. Alejandro Bruhn Cross Department of Intensive Care, Erasme Hospital, Free University of Brussels, Belgium. , Fac. Medicine, P. Catholic University of Chile
2006 Mar - 2008 Dec: Thesis director Paola Mrs. Krall Opazo.. "The cotrisol and its receptor in the genesis of hypertension: etiopathologic possible mechanism." To obtain the title of Biochemistry, Fac. DC BB, P. Catholic University of Chile
2007 Apr - 2007 Jun: Teacher in class Module I: Thyroid Pathology Psychoendocrinology. Diploma Biological and Evolutionary Bases of Psychiatry, Version 2007, Fac. Medicine, P. Catholic University of Chile
2007 Jun - 2007 Jun: Teacher in class "Molecular Basis of Hypertension" in the undergraduate course: Molecular Basis of Pathology. BIO 241 C, Fac. DC BB, P. Catholic University of Chile
2007 Mar - 2009 Dec: Thesis director Mr. Mauricio Morales Bustamante. "HSD11B1 gene polymorphisms in essential hypertension." To obtain the title of Biochemistry, Fac. DC BB, P. Catholic University of Chile
2008 Mar - 2010 Dec: Thesis director Dr. Rodrigo Muñoz. "Expression of 11 beta-hydroxysteroid dehydrogenase type 1 (11 beta-HSD1) in visceral and subcutaneous adipose tissue in morbidly obese patients." For the degree of Doctor of Medical Sciences, Fac. Medicine, P. Catholic University of Chile
2009 Mar - 2009 Jun: MDO3031 Teaching Course: "Basic biological processes in human disease" (1st semester). Doctoral Program in Medical Sciences, Fac. DC BB. P. Universidad Catolica de Chile
2010 - 2013 Director Doctor Medical Sciences Thesis. Dr. Cristian Carvajal. Role of 11beta-hydroxysteroid dehydrogenase type 2 (11BHSD2) in the pathogenesis of arterial hypertension. Pontificia U Catolica de Chile
2011 -: Participation in seminars Fisologia Department, Faculty of Biological Sciences, Pontificia Universidad Catolica de Chile. Faculty of Cs Bs. P. Catholic University of Chil
2011 Mar - Director of thesis of Mr. Cristobal Fuentes Zuniga. Thesis: Role of estrogen in the activity of the enzyme aldosterone synthase (CYP11B2) and its relationship with familial hyperaldosteronism type 1. Valparaiso University. Pontificia U Catolica de Chile
2012 Mar - Director of thesis Miss Alejandra Tapia Castillo.. Thesis: Role of the small GTPase RAC1 in the pathogenesis of arterial hypertension. University of Santiago, Chile Pontifical Catholic U
-
Carlos Fardella
PONTIFICIA UNIVERSIDAD CATOLICA DE CHILE
Chile, 1990
Fogarty International Fellowship supported by Department of Health and Human Services. Public Health Service. National Institute of Health, USA.
-
All Awards listed
PONTIFICIA UNIVERSIDAD CATOLICA DE CHILE
Chile
1982: Award for the best graduate student of the School of Universidad de Chile 1982 Medicina.Promocion 1986: Best average discharge of the Fellowship in Internal Medicine. Faculty of Medicine. P. Catholic University of Chile 1988: Fellowship in Endocrinology and Metabolism passed with Distinction. Faculty of Medicine. P. Catholic University of Chile. 1990: Fogarty International Fellowship supported by Department of Health and Human Services. Public Health Service. National Institute of Health, USA. 1992: Awarded Honorary President of the Republic. Ministry of Development and Planning (Ministry of Planning). Santiago, Chile. 1993: Henry Christian Memorial Award for Excellence in Research, supported by the American Federation for Clinical research (AFCR) Whashington, USA. 1994: Trainee Investigator Award supported by the Association of American Physicians (AAP), American Society for Clinical Investigation (ASCI) and the American Federation for Clinical Research (AFCR). Washington DC, USA. 1994: Chile Medical Society Award for the best paper published in Chile. Santiago, Chile. 1995: International Society for Heart Research Award. Latin-American Section.Santiago, Chile 1995: Dr. Ramon Rosas Award, awarded by the Chilean Society of Hypertension. Concepcion, Chile. 1995: Prize Chilean Society of Endocrinology and Metabolism at the best paper presented at the Annual Conference of Endocrinology and Metabolism. Panimavida, Chile. 1995: Boehringer Manheim Prize, awarded by the Chilean Society of nephrology. Concepcion, Chile. 1996: Latin-American Society of Endocrinology Award. Misiones, Argentina 1996: Prize Chilean Society of Endocrinology and Metabolism at the best paper presented at X Congress. Valdivia, Chile. 1996: Prize Chilean Society of Neurology, Psychiatry best paper submitted to Congress 51. Viña del Mar, Chile. 1996: Prize of Chile Medical Society. XVII Chilean Congress of Internal Medicine. Santiago, Chile. 1997: Award for Excellence in Research, awarded by the P. Universidad Catolica de Chile. Santiago, Chile. 1997: Award laboratory Saval, awarded by the Medical Society of Chile. XIX Congress of Internal Medicine, Santiago, Chile. 1998: Prize Chilean Society of Endocrinology and Metabolism at the best paper presented at XI Chilean Congress and Chilean-Argentine Conference IV. Chillan, Chile. 1998: Chile Medical Society Award for the best paper submitted to the XX Congress of Internal Medicine Chile, Santiago, Chile. 1999: Dr. Ramon Rosas Award, awarded by the Chilean Society of Hypertension. Marbella, Chile 1999. 1999: Chilean Society of Cardiology and Cardiovascular Surgery Award. Puerto Varas, Chile. 1999. 1999: Chilean Society of Endocrinology and Metabolism Prize, awarded to the best work of scholarship presented to the Annual Conference. Marbella, Chile. 1999. 2000: Prize Chilean Society of Endocrinology and Metabolism at the best paper presented at XII Congress. Pucon, Chile. 2000. 2001: Medical Society of Chile Award for the best paper published in Chile in 2000, Santiago, Chile. 2001. 2001: Prize Chilean Society of Endocrinology and Metabolism at the best paper presented at the Annual Conference. La Serena, Chile. 2001. 2002: Chilean Academy of Medicine 2002 Award, established to distinguish a line of research in Chile. Award was made ??under the Chilean XXIV Congress of Internal Medicine. Santiago, Chile. 2002. 2005: Prize Chilean Society of Endocrinology and Diabetes the best work submitted to Congress 2005 Pucon Ortiz E, Mosso L, Carvajal C, Krall P, Garrido JL, Artigas R, Fardella C. Experience in the diagnosis of primary aldosteronism in essential hypertension 1000 Chileans. XVI Chilean Congress of Endocrinology and Diabetes. Pucón November 10-12, 2005. 2005: Prize Chilean Society of Endocrinology and Diabetes at the best free work submitted to Congress in Pucon: Tala H. González A, Garrido JL, Carvajal C, J Tobar, Solar A, Rojas P, Campino C, Arteaga E, Fardella C. New splicing site mutation in the MEN1 gene expressed predominantly familial isolated hyperparathyroidism. XVI Chilean Congress of Endocrinology and Diabetes. Pucon, November 10-12, 2005 2006: Nomination as World expert in the field of hypertension and mineralocorticoid. Designation by the Endocrine Society. 2007: Award Best Free Workplace: Different phenotypic expression of familial primary aldosteronism type I in a family group with de novo mutation. First communication worldwide. Chilean Society of Endocrinology and Diabetes, Valdivia, December 2007. 2008: Best Paper Award: Designing scale sonographic predictor of malignancy in thyroid nodules: preliminary report. Dominguez JM, Baudrand R, Arteaga E, Mosso L, Campusano C, Cavada G, Torres T, Solar A, Arias T, Pizarro A, Gómez M, C. Fardella XXX Chilean Congress of Internal Medicine. Santiago October 23-25??, 2008. 2008: Best Scoring: Primary aldosteronism with spironolactone Treated patients improved the serum TGF-B1 levels. Carvajal CA, Herrada AA, Castillo RC, Contreras FJ, Stehr CB, Mosso LM, Kalergis AM, Fardella CE. 90th Annual Meeting s The Endocrine Society, San Francisco-USA, June 15-18, 2008. 2009: Award Best Free Workplace: Usefulness of intraoperative PTH (iPTH) as a predictor of surgical cure in primary hyperparathyroidism (HPT 1) Dominguez JM, Goñi I, Leon A, González M, Claure R, Arteaga E, Campusano C, C Fardella Lopez JM, Mosso L, Rodríguez JA, González G. XVII Chilean Congress of osteology and Mineral Metabolism. Santiago, 24-25 April 2009. 2009: Travel Grant Award: Overexpression of 11 beta-hydroxysteroid dehydrogenase type I in hepatic and visceral adipose tissue is Associated with metabolic disorders in morbidly obese patients. Baudrand R, Carvajal CA, Riquelme A, Morales M, Solis N, Pizarro M, Escalona A, Boza C, Perez G, Domínguez A, Arrese M, Fardella CE. The 91th Annual Meeting Endocrine Society, Washington USA, June 10-13 2009. 2009: Award for the best clinical work XX Chilean Congress of Endocrinology and Diabetes. Central obesity and metabolic syndrome are associated with portal systemic hypercortisolism and not supported by elevated urinary tetrahydro derivatives. Baudrand R, Campino C, Carvajal CA, Olivieri O, Guidi G, Faccini G, Pasini F, Sateler J, Cornejo J, San Martin B, Domínguez JM, Mosso LM, Owen G, Kalergis AM, Fardella C. XX Chilean Congress Endocrinology and Diabetes. Coquimbo, Chile, 12-14 November, 2009. 2010: Awards: Presidential Poster Competition and Travel Award: A novel unequal cross-over mutation Between adnd CYP11B1 CYP11B2 genes causes familial hyperaldosteronism type I. Carvajal C, Sther C, Gonzalez P, Riquelme E, Montero T, Santos M, Kalergis A, Fardella C. 92st Annual Meeting The Endocrine Society, San Diego-USA, June 17-22, 2010. 2010: Outstanding Abstract Award. Central obesity and the metabolic syndrome are Associated with systemic hypercortisolism website and not supported by the raise of urinary corticosteroid metabolites. Baudrand R, Campino C, Carvajal CA, Olivieri O, Guidi G, Faccini G, Pasini F, Sateler J, Cornejo J, San Martin B, Dominguez JM, Mosso LM, Owen G, Kalergis AM, Fardella C. The 92st Annual Meeting Endocrine Society, San Diego-USA, June 17-22, 2010. 2010: President Poster Award. Glucocorticoid-remediable aldosteronism (familial primary hyperaldosteronism type 1) in children: prevalence, clinical and biochemical characteristics. Garcia H, Aglony M, Martinez A, Carvajal C, Campino C, Bancalari R, Avalos C, C. Fardella 49th Annual Meeting of the European Society for Paediatric Endocrinology (ESPE), September 22-25, 2010, Prague-Czech Republic. 2010: Best Paper Award Clinico Basico, SLEP R Bancalari 2010; Garcia M; Aglony M; Martinez-Aguayo A; Carvajal C; Campino C; Mericq V; Fardella C. Hyperaldosteronism Type I familial in children: prevalence, clinical and biochemical characteristics. SLEP 2010, Costa do Sauipe-Brazil, 27-30 October, 2010 2010: Prize "Dr. Alfredo Commentz 2010" Godoy A, Garcia M. M, Campino C, Carvajal C, Aglony M, Martinez A, Bancalari R, Cerda J, Arnaiz P, Fardella metabolic syndrome C. and its association with endothelial dysfunction measured as sensitivity C-reactive protein in children and adolescents Chileans. 50th Chilean Congress of Pediatrics, Pucon-Chile, 28-31 October, 2010. 2011: Oustanding Abstract Award, Carvajal C, Campino C, Martinez-Aguayo A, Tichauer JE, Bancalari R, Valdivia C, Trejo P, Aglony A, Baudrand R, Lagos CF, Garcia H, Fardella CE. A new presentation of chimeric CYP11B1 / CYP11B2 gene with low prevalence of primary aldosteronism and atypical gene segregation pattern. 93rd Annual Meeting of The Endocrine Society. Boston, MA-USA June 4-7, 2011. 2011: Best Paper Award Free. Carvajal CA, Campino C, Martinez-Aguayo A, Tichauer JE, Bancalari R, Valdivia C, Trejo P, Aglony M, R Baudrand, Lagos CF, Garcia H, Fardella CE. Inhibition of the activity of the chimeric gene CYP11B1 / CYP11B2 by sex steroids masks table origin in adult hypertensive. XXII Chilean Congress of Endocrinology and Diabetes. Antofagasta-Chile, 10-12 November, 2011. 2011: SOCHED Award 2011 for the best work published in Endocrinology and Diabetes topics 2010 Martinez-Aguayo A, Aglony M, Campino C, Garcia H, Bancalari R, Bolte L, Avalos C, Loureiro C, Carvajal CA, Avila A, Perez V, Inostroza A, Fardella CE. Aldosterone, plasma renin activity, and aldosterone / renin ratio in normotensive healthy pediatric population. XXII Chilean Congress of Endocrinology and Diabetes. Antofagasta-Chile, 10-12 November, 2011. 2011: Best Work Research Prize Alfredo Commenz Löffler. Loureiro C, Campino C, Godoy I, Garcia M, Aglony M, Bancalari R, Martinez-Aguayo A, Carvajal C, C. Dano Fardella vascular abnormalities in hypertensive children and cortisol metabolism. Congress of Pediatrics 2011 Chilean Society of Pediatrics 2012: The Endocrine Society Outstanding Abstract Award: Carlos F Lagos, Andrea Vecchiola, Juan Tichauer, Fidel Allende, Carolina Valdivia, Christopher A Fuentes, Sandra Solari, Carmen Campino Rene Baudrand, Mariana Cifuentes, Gareth I Owen, Cristian A Carvajal, Carlos E Fardella. Identification of Novel Inhibitors of 11beta-hydroxysteroid Dehydrogenase Type 1 (11BHSD1) by In Vitro Screening and Confirmation. 94th Annual Meeting & Expo The Endocrine Society's. Houston, Texas-USA. June 23-26, 2012 2012: Translational Award for Best Work: Knock-Down Inhibition of gene 11 beta-hydroxysteroid dehydrogenase type 2 (HSD11B2) gene affects the response via mineralocoritocidea in endothelial cell line EaHy926. Carvajal CA, Tapia A, Fuentes C, Valdivia C, CF Lagos, Allende F, Solari S, Campino C, Baudrand R, Martinez A, Owen GI, Fardella CE. SOCHED XXIII Congress, Valdivia 11 to October 13, by 2012. 2012: "Outstanding Researcher 2012". Chilean Society of Endocrinology and Diabetes. SOCHED XXIII Congress, Valdivia 11 to October 13, by 2012. 2013: SOCHED 2013 International Award for the best paper published in the areas of endocrinology and Diabetes 2012 Carvajal CA, Campino C, Martinez-Aguayo A, Tichauer JE, Bancalari R, Valdivia C, Trejo P, Aglony M, R Baudrand, Lagos CF, Mellado C, Garcia H, Fardella CE. A new presentation of the chimeric CYP11B1 / CYP11B2 gene with low prevalence of primary aldosteronism and atypical gene segregation pattern.Hypertension. 2012 Jan, 59 (1): 85-91 2013: I Preset postulating a Prize for Best Work in the Area Clinic. XXIV Chilean Congress of Endocrinology and Diabetes. Santiago-Chile, November 2013 2013: President Poster Award. Plasma matrix metalloproteinases activity in hypertensive children due to 11ß-HSD2 activity deficiency "Poster Award at the 9th Joint Meeting of Paediatric Endocrinology, September 19-22, 2013, Milan, Italy. 2013: Carvajal ...... CPG methylation in 11 beta-hydroxysteroid dehydrogenase type2 promoter is eased in adult essential hypertensives, to be Presented at ENDO 2013, June 17, 2013: Project was awarded the First Contest Fondef IDeA Applied Science Program. Identification and development of inhibitors of the enzyme 11 beta-HSD1 for the treatment of arterial hypertension and metabolic syndrome. Interconsulta Magazine, UC School of Medicine, June 2013 2013: Best Researcher Award, UC School of Medicine, 2013 2013: Prize Competition Patenting V UC. UC Vice-Rector for Innovation, 2013. 2013: Publication featured in The Endocrine Society and MedPage. High-salt diet May boost cortisol. By Fiore F, S. Writer Published May 20, 2013 Reviewed by F Perry Wilson MD, MSCE, Instructor of Medicine, Perelman Sch. of Med. at the University of Pennsylvania and Dorothy Caputo, MA, BSN, Nurse Planner. Primary source: Clim. Endocrinol. Baudrand R, et al. High sodium intake is Associated with Increased glucorticoid production, insulin resistance, and metabolic syndrome. Clin Endocrinol 2013; DOI 10,111 / cen.12225
Tiroglobulina y sus limitaciones en el seguimiento del carcinoma diferenciado del tiroides: Report of two cases |
Hyporeninemia and arterial hypertension Hipertensión Arterial hiporreninémica |
Mutations in the CYP21B gene in a Chilean population with simple virilizing congenital adrenal hyperplasia |
A possible association between primary aldosteronism and a lower beta-cell function - Reply |
Cautions over idiopathic aldosteronism |
Novel radiologic and metabolomic profiling of adrenal tumors to identify cardiometabolic risk |
ADRENAL DYSREGULATION IN CHILDREN BORN EXTREMELY PRETERM=> THE ROLE OF INCREASED MINERALOCORTICOID RECEPTOR ACTIVATION ON BLOOD PRESSURE AND VASCULAR DAMAGE |
ALDOSTERONE DYSREGULATION IN METABOLIC SYNDROME, OBESITY AND INFLAMMATION=> CLINICAL AND IN VITRO STUDIES. |
EFFECTIVE REDUCTION OF RHO KINASE ACTIVATION AND ERM PHOSPHORYLATION IN CONGESTIVE HEART FAILURE AND IN SEVERE HYPERTENSION. A CLINICAL AND TRANSLATIONAL STUDY |
NOVEL BIOCHEMICAL AND EPIGENETIC STUDIES IN 11BETA-HYDROXYSTEROID DEHYDROGENASE 2 GENE AS A TARGET FOR ENDOCRINE HYPERTENSION. |
Consorcio Tecnológico en Biomedicina aplicada para el desarrollo de nuevas estrategias de prevención, diagnóstico y tratamiento de enfer,edades humanas. |
IDENTIFICACION Y DESARROLLO DE INHIBIDORES DE LA ENZIMA 11b-HSDH1 PARA EL TRATAMIENTO DE LA HIPERTENSION ARTERIAL Y SINDROME METABOLICO |
SALT INTAKE IN ESSENTIAL HYPERTENSION=> STUDIES OF NEW BIOCHEMICAL AND GENETIC MECHANISMS TO IDENTIFY ITS ETIOLOGY |
PRIMARY ALDOSTERONISM AND HSD11B2 ENZYME ACTIVITY DEFECTS IN PEDIATRIC POPULATION AND ITS IMPACT ON THE GENERATION OF ENDOTHELIAL INJURY, OXIDATIVE STRESS AND ARTERIAL HYPERTENSION |
Nuevo Test diagnóstico molecular para identificar causas de hipertensión arterial con y sin síndrome metabólico. |
EN LA HIPERTENSION ARTERIAL CON ALTO RIESGO CARDIOVASCULAR LA ACTIVACION DE RHO KINASA MEDIA EL REMODELADO PATOLOGICO=> UN ESTUDIO CLINICO Y MOLECULAR EXPERIMENTAL |
EN LA HIPERTENSION ARTERIAL CON ALTO RIESGO CARDIOVASCULAR LA ACTIVACION DE RHO KINASA MEDIA EL REMODELADO PATOLOGICO=> UN ESTUDIO CLINICO Y MOLECULAR EXPERIMENTAL |
EVALUACION CLINICO-MOLECULAR DEL ROL DE LAS DESHIDROGENASAS TIPO 1 Y 2 (11BHSD1 Y 11BHSD2) EN LA GENESIS DE LA HIPERTENSION ARTERIAL HIPORRENNEMICA. |
EVALUACION CLINICO-MOLECULAR DEL ROL DE LOS RECEPTORES DE GLUCOCORTICOIDES Y MINERALOCORTICOIDES EN LA GENESIS DE LA HIPERTENSION HIPORRENINEMICA. |
CARACTERIZACION CLINICO-MOLECULAR DE LA HIPERTENSION ARTERIAL HIPORRENINEMICA NO MEDIADA POR ALDOSTERONA |
BASES CLINICO-MOLECULARES DE LA HIPERTENSION ARTERIAL HIPORRENINEMICA=> DISFUNCION DEL CITOCROMO P450C11? |
ROL DEL CITOCROMO P450C11 AS (ALDOSTERONE SYNTHASE) EN LA GENESIS DE HIPERTENSION ARTERIAL EN EL HOMBRE => CARACTERIZACION MOLECULAR |
ROL DE LA HIPERCALCEMIA CRONICA EN LA GENESIS DE HIPERTENSION ARTERIAL EN EL HOMBRE=> SIGNIFICADO DE LA CONCENTRACION INTRACELULAR DE CALCIO. |
REACTIVIDAD VASCULAR E HIPERTENSION ARTERIAL EN EL HIPERPARATIROIDISMO PRIMARIO=> |